EA201490332A1 - Соединения (тиено[2,3-b][1,5]бензоксазепин-4-ил)пиперазин-1-ила, обладающие двойной активностью обратных агонистов рецепторов h1/антагонистов рецепторов 5-ht - Google Patents
Соединения (тиено[2,3-b][1,5]бензоксазепин-4-ил)пиперазин-1-ила, обладающие двойной активностью обратных агонистов рецепторов h1/антагонистов рецепторов 5-htInfo
- Publication number
- EA201490332A1 EA201490332A1 EA201490332A EA201490332A EA201490332A1 EA 201490332 A1 EA201490332 A1 EA 201490332A1 EA 201490332 A EA201490332 A EA 201490332A EA 201490332 A EA201490332 A EA 201490332A EA 201490332 A1 EA201490332 A1 EA 201490332A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- receptors
- benzoxazepin
- ila
- thieno
- piperazin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
В настоящей заявке описан обратный агонист рецепторов H/антагонист рецепторов 5-НТ, обладающий двойной активностью, согласно формуле:его применение, а также способы его получения.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161528893P | 2011-08-30 | 2011-08-30 | |
PCT/US2012/051833 WO2013032804A1 (en) | 2011-08-30 | 2012-08-22 | (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201490332A1 true EA201490332A1 (ru) | 2014-06-30 |
EA024248B1 EA024248B1 (ru) | 2016-08-31 |
Family
ID=46829875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201490332A EA024248B1 (ru) | 2011-08-30 | 2012-08-22 | Соединения (тиено[2,3-b][1,5]бензоксазепин-4-ил)пиперазин-1-ила, обладающие двойной активностью обратных агонистов рецепторов h1/антагонистов рецепторов 5-ht |
Country Status (22)
Country | Link |
---|---|
US (1) | US9512140B2 (ru) |
EP (1) | EP2751115B1 (ru) |
JP (1) | JP6042436B2 (ru) |
KR (1) | KR101596607B1 (ru) |
CN (1) | CN103958523B (ru) |
AU (1) | AU2012300451B2 (ru) |
BR (1) | BR112014004557A2 (ru) |
CA (1) | CA2843514C (ru) |
DK (1) | DK2751115T3 (ru) |
EA (1) | EA024248B1 (ru) |
ES (1) | ES2650225T3 (ru) |
HR (1) | HRP20171824T1 (ru) |
HU (1) | HUE034845T2 (ru) |
LT (1) | LT2751115T (ru) |
MX (1) | MX350419B (ru) |
NO (1) | NO2776955T3 (ru) |
PL (1) | PL2751115T3 (ru) |
PT (1) | PT2751115T (ru) |
RS (1) | RS56537B1 (ru) |
SI (1) | SI2751115T1 (ru) |
WO (1) | WO2013032804A1 (ru) |
ZA (1) | ZA201400874B (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014000379A2 (pt) * | 2011-07-08 | 2017-01-10 | Lilly Co Eli | compostos de (trieno[2,3-1)][1,5]benzoxazepin-4-il)piperazin-1-ila como atividade dupla de antagonistas de 5-ht2a /agonistas inversos de h1 |
DK2943498T3 (en) | 2013-01-14 | 2017-10-23 | Lilly Co Eli | (THIENO [2,3-B] [1,5] BENZOXAZEPIN-4-YL) PIPERAZIN-1-YL COMPOUNDS AS H1-INVERSE AGONISTS / 5-HT2A DOUBLE EFFECTS |
TW201625644A (zh) | 2014-04-29 | 2016-07-16 | 美國禮來大藥廠 | 作為選擇性5-HTA反向促效劑之(噻吩并[2,3-b][1,5]苯并氧氮呯-4-基)哌嗪-1-基化合物 |
WO2018177993A1 (de) | 2017-03-31 | 2018-10-04 | Bayer Cropscience Aktiengesellschaft | Pyrazole zur bekämpfung von arthropoden |
WO2018234488A1 (en) | 2017-06-23 | 2018-12-27 | Basf Se | SUBSTITUTED CYCLOPROPYL DERIVATIVES |
WO2019185413A1 (en) | 2018-03-27 | 2019-10-03 | Basf Se | Pesticidal substituted cyclopropyl derivatives |
CN113767094A (zh) * | 2018-12-21 | 2021-12-07 | 奥格达股份有限公司 | 3-甲基-1,2,4-噻二唑-5-碳酰肼及其甲基-d3氘代形式的合成 |
MX2023009402A (es) | 2021-02-11 | 2023-08-23 | Basf Se | Derivados de isoxazolina sustituida. |
EP4043444A1 (en) | 2021-02-11 | 2022-08-17 | Basf Se | Substituted isoxazoline derivatives |
WO2024089216A1 (en) | 2022-10-27 | 2024-05-02 | Syngenta Crop Protection Ag | Novel sulfur-containing heteroaryl carboxamide compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7395251B2 (en) * | 2005-07-01 | 2008-07-01 | International Business Machines Corporation | Neural networks for prediction and control |
US7807828B2 (en) * | 2005-08-11 | 2010-10-05 | Hypnion, Inc. | Olanzapine analogs and methods of use thereof |
-
2012
- 2012-08-22 EP EP12756856.6A patent/EP2751115B1/en active Active
- 2012-08-22 HU HUE12756856A patent/HUE034845T2/en unknown
- 2012-08-22 US US14/131,695 patent/US9512140B2/en active Active
- 2012-08-22 EA EA201490332A patent/EA024248B1/ru not_active IP Right Cessation
- 2012-08-22 DK DK12756856.6T patent/DK2751115T3/en active
- 2012-08-22 RS RS20171126A patent/RS56537B1/sr unknown
- 2012-08-22 MX MX2014002473A patent/MX350419B/es active IP Right Grant
- 2012-08-22 CN CN201280040793.9A patent/CN103958523B/zh not_active Expired - Fee Related
- 2012-08-22 PL PL12756856T patent/PL2751115T3/pl unknown
- 2012-08-22 LT LTEP12756856.6T patent/LT2751115T/lt unknown
- 2012-08-22 WO PCT/US2012/051833 patent/WO2013032804A1/en active Application Filing
- 2012-08-22 PT PT127568566T patent/PT2751115T/pt unknown
- 2012-08-22 BR BR112014004557A patent/BR112014004557A2/pt not_active IP Right Cessation
- 2012-08-22 AU AU2012300451A patent/AU2012300451B2/en not_active Ceased
- 2012-08-22 SI SI201231078T patent/SI2751115T1/sl unknown
- 2012-08-22 KR KR1020147004807A patent/KR101596607B1/ko active IP Right Grant
- 2012-08-22 JP JP2014528453A patent/JP6042436B2/ja not_active Expired - Fee Related
- 2012-08-22 ES ES12756856.6T patent/ES2650225T3/es active Active
- 2012-08-22 CA CA2843514A patent/CA2843514C/en not_active Expired - Fee Related
- 2012-11-09 NO NO12848689A patent/NO2776955T3/no unknown
-
2014
- 2014-02-05 ZA ZA2014/00874A patent/ZA201400874B/en unknown
-
2017
- 2017-11-22 HR HRP20171824TT patent/HRP20171824T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
JP2014525440A (ja) | 2014-09-29 |
PT2751115T (pt) | 2017-12-20 |
AU2012300451B2 (en) | 2016-10-13 |
CN103958523A (zh) | 2014-07-30 |
KR20140051355A (ko) | 2014-04-30 |
ZA201400874B (en) | 2015-10-28 |
CA2843514C (en) | 2017-01-10 |
KR101596607B1 (ko) | 2016-02-22 |
HRP20171824T1 (hr) | 2017-12-29 |
NO2776955T3 (ru) | 2018-06-02 |
EA024248B1 (ru) | 2016-08-31 |
US9512140B2 (en) | 2016-12-06 |
PL2751115T3 (pl) | 2018-02-28 |
RS56537B1 (sr) | 2018-02-28 |
MX350419B (es) | 2017-09-05 |
WO2013032804A1 (en) | 2013-03-07 |
HUE034845T2 (en) | 2018-03-28 |
BR112014004557A2 (pt) | 2017-05-30 |
DK2751115T3 (en) | 2017-10-23 |
EP2751115A1 (en) | 2014-07-09 |
ES2650225T3 (es) | 2018-01-17 |
US20140171411A1 (en) | 2014-06-19 |
CN103958523B (zh) | 2016-07-27 |
JP6042436B2 (ja) | 2016-12-14 |
SI2751115T1 (sl) | 2017-11-30 |
EP2751115B1 (en) | 2017-09-20 |
LT2751115T (lt) | 2017-12-27 |
AU2012300451A1 (en) | 2014-01-30 |
MX2014002473A (es) | 2016-09-26 |
CA2843514A1 (en) | 2013-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201490332A1 (ru) | Соединения (тиено[2,3-b][1,5]бензоксазепин-4-ил)пиперазин-1-ила, обладающие двойной активностью обратных агонистов рецепторов h1/антагонистов рецепторов 5-ht | |
EA201490912A1 (ru) | Производные [1,2,3]триазоло[4,5-d]пиримидина в качестве агонистов каннабиноидного рецептора 2 | |
SMT201500165B (it) | Composti di n-(1h-indazol-4-il) imidazo[1,2a] piridina-3-carbossammide sostituiti come inibitori di tirosin-chinasi di recettore di tipo III | |
EA201290940A1 (ru) | Новые соединения как селективные антагонисты рецептора nk3, фармацевтическая композиция и методы их использования при нарушениях, опосредованных nk3 рецепторами | |
EA201590873A1 (ru) | Соединения, обладающие активностью антагонистов мускариновых рецепторов и агонистов бета2 адренергических рецепторов | |
IN2012DN01241A (ru) | ||
EA201290355A1 (ru) | Спиропиперидиновые соединения в качестве антагонистов рецептора orl-1 | |
EA201391662A1 (ru) | Соединения с активностью антагонистов мускариновых рецепторов и агонистов адренергического рецептора бета2 | |
MY160665A (en) | Spiropiperidine compounds as orl-1 receptor antagonists | |
SI2782915T1 (sl) | Derivati (1,2,3)triazolo(4,5-d)pirimidina kot agonisti agonistov kanabinoidnega receptorja 2 | |
BR112014012409B8 (pt) | Composições de buprenorfina e antagonistas do receptor mu-opioide | |
HRP20180475T1 (hr) | (TIENO[2,3-b][1,5]BENZOKSAZEPIN-4-IL)PIPERAZIN-1-ILNI SPOJEVI, DVOJNO AKTIVNI KAO INVERZNI AGONISTI H1/ANTAGONISTI 5-HT2A | |
EA201391744A1 (ru) | Производные 2-амино-3-(имидазол-2-ил)-пиридин-4-она и их применение в качестве ингибиторов киназы рецептора vegf | |
EA201390568A1 (ru) | СОЕДИНЕНИЯ 4-ЗАМЕЩЕННОГО-3-БЕНЗИЛОКСИБИЦИКЛО[3.1.0]ГЕКСАНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGLuR 2/3 | |
EA201390966A1 (ru) | Замещенные соединения [(5h-пирроло[2,1-c][1,4]бензодиазепин-11-ил)пиперазин-1-ил]-2,2-диметилпропановой кислоты в качестве обратных агонистов h1/антагонистов 5-htдвойного действия | |
EA201591099A1 (ru) | ТИЕНО([2,3-b][1,5]БЕНЗОКСАЗЕПИН-4-ИЛ)ПИПЕРАЗИН-1-ИЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ АГЕНТОВ С ДВОЙНОЙ АКТИВНОСТЬЮ: ОБРАТНЫХ АГОНИСТОВ H1/АНТАГОНИСТОВ 5-HT | |
NZ710361A (en) | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities | |
UA109581C2 (uk) | Сполуки з активністю антагоністів мускаринових рецепторів і агоністів адренергічного рецептора бета2 | |
TH137278B (th) | อนุพันธ์ 2,3-ไดไฮโดร-1h-อินเดน-1-อิล-2,7-ไดแอซาสไพ[3.5]โนเนน | |
UA54879U (ru) | Применение антагониста рецепторов интерлейкина-1 как средства антиоксидантного действия |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |